Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,409 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetes.
Thazhath SS, Marathe CS, Wu T, Chang J, Khoo J, Kuo P, Checklin HL, Bound MJ, Rigda RS, Horowitz M, Jones KL, Rayner CK. Thazhath SS, et al. Among authors: kuo p. Diab Vasc Dis Res. 2017 Jan;14(1):59-63. doi: 10.1177/1479164116666761. Epub 2016 Oct 20. Diab Vasc Dis Res. 2017. PMID: 27941058 Free article. Clinical Trial.
Gastric emptying, diabetes, and aging.
Kuo P, Rayner CK, Horowitz M. Kuo P, et al. Clin Geriatr Med. 2007 Nov;23(4):785-808, vi. doi: 10.1016/j.cger.2007.06.009. Clin Geriatr Med. 2007. PMID: 17923338 Review.
The nitric oxide synthase inhibitor, Ng-nitro-L-arginine-methyl-ester, attenuates the delay in gastric emptying induced by hyperglycaemia in healthy humans.
Kuo P, Gentilcore D, Nair N, Stevens JE, Wishart JM, Lange K, Gilja OH, Hausken T, Horowitz M, Jones KL, Rayner CK. Kuo P, et al. Neurogastroenterol Motil. 2009 Nov;21(11):1175-e103. doi: 10.1111/j.1365-2982.2009.01321.x. Epub 2009 May 21. Neurogastroenterol Motil. 2009. PMID: 19460102 Clinical Trial.
Effects of metoclopramide on duodenal motility and flow events, glucose absorption, and incretin hormone release in response to intraduodenal glucose infusion.
Kuo P, Bellon M, Wishart J, Smout AJ, Holloway RH, Fraser RJ, Horowitz M, Jones KL, Rayner CK. Kuo P, et al. Am J Physiol Gastrointest Liver Physiol. 2010 Dec;299(6):G1326-33. doi: 10.1152/ajpgi.00476.2009. Epub 2010 Sep 9. Am J Physiol Gastrointest Liver Physiol. 2010. PMID: 20829521 Free article. Clinical Trial.
The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled Trial.
Thazhath SS, Marathe CS, Wu T, Chang J, Khoo J, Kuo P, Checklin HL, Bound MJ, Rigda RS, Crouch B, Jones KL, Horowitz M, Rayner CK. Thazhath SS, et al. Among authors: kuo p. Diabetes. 2016 Jan;65(1):269-75. doi: 10.2337/db15-0893. Epub 2015 Oct 15. Diabetes. 2016. PMID: 26470783 Clinical Trial.
The stomach that "cracked" under pressure.
Kuo P, Pieterse S, Harley HA. Kuo P, et al. Gastroenterology. 2010 Jan;138(1):44, 403. doi: 10.1053/j.gastro.2009.07.079. Epub 2009 Nov 21. Gastroenterology. 2010. PMID: 19932658 No abstract available.
2,409 results